Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
|
6 Months Ended |
Aug. 31, 2019 |
Aug. 31, 2018 |
| Cash Flows from Operating Activities |
|
|
| Net loss |
$ (6,896,593)
|
$ (7,067,940)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Depreciation and amortization |
365,739
|
211,658
|
| Stock-based compensation expense |
1,734,018
|
2,191,139
|
| Accrued interest |
215,433
|
0
|
| Loss on revaluation of warrants |
8,483
|
0
|
| Debt accretion |
1,035,888
|
0
|
| Deferred financing costs |
66,327
|
0
|
| Gain on conversion of convertible notes |
(232,565)
|
0
|
| Changes in operating assets and liabilities: |
|
|
| Sales tax and tax credits receivable |
(123,194)
|
47,725
|
| Prepaid expenses |
(22,987)
|
359,072
|
| Accounts payable and accrued liabilities |
(1,385,978)
|
349,723
|
| Net cash used in operating activities |
(5,235,429)
|
(3,908,623)
|
| Cash Flows from Investing Activities |
|
|
| Investment in joint venture |
(500,000)
|
0
|
| Additions to property, plant and equipment |
(1,202,766)
|
(1,038,775)
|
| Additions to intangible assets |
(82,432)
|
(66,195)
|
| Net cash used in investing activities |
(1,785,198)
|
(1,104,970)
|
| Cash Flows from Financing Activities |
|
|
| Proceeds from sale of common shares |
40,273,751
|
0
|
| Share issuance costs |
(1,106,370)
|
0
|
| Repayment of long-term debt |
(26,326)
|
(26,808)
|
| Net cash provided from (used in) financing activities |
39,141,055
|
(26,808)
|
| Effect of exchange rate changes |
(22,778)
|
(191,846)
|
| Net change in cash |
32,097,650
|
(5,232,247)
|
| Cash, beginning of period |
5,833,390
|
8,149,713
|
| Cash, end of period |
37,931,040
|
2,917,466
|
| Supplemental Disclosure of Cash Flow Information: |
|
|
| Income tax paid |
0
|
0
|
| Interest paid |
$ 30,497
|
$ 26,234
|